D-0455-2017 Class II Terminated
FDA drug recall D-0455-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 12, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jun 29, 2018). Affected quantity: 8,537 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 8, 2017
- Initiation Date
- Jan 12, 2017
- Termination Date
- Jun 29, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,537 bottles
Product description
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0455-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026